Floatz logo

Radiprodil

Focal Cortical Dysplasia

GRIN Therapeutics, Inc.Small moleculePhase 1/2Active
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
35/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Focal Cortical Dysplasia cohort.

Asset / SponsorPhaseRating
Everolimus
NYU Langone Health
Phase 2B
svg103
Sovargen
Phase 1/2CCC
Carbamazepine
GRIN Therapeutics, Inc.
Phase 1CC
Itraconazole
GRIN Therapeutics, Inc.
Phase 1CC
BLOOD, WHOLE
King's College Hospital NHS Trust
N/AD

Same molecule, other indications

Radiprodil is also rated in:

diabetic neuropathyDormant
CCC
Indicative ·
49 / 100
View asset →
tuberous sclerosisDormant
CCC
Indicative ·
48 / 100
View asset →
infantile spasmsDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →